Phase II study of fixed dose-rate infusion of gemcitabine and UFT combination chemotherapy in patients with advanced bile duct cancer: Daegu Gyeoungbuk Oncology Group.Suyoung Bae,Hongje Ryoo, Myungil Kim, Keun Hyoung Lee, Juhan Kim,Youngrok Do,Hoyoung Song,Young Tae Chae,Wonha Lee,Jongmi Baekmag(2010)引用 24|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要